Medpace and Voximetry Announce Strategic Partnership to Drive Excellence in Clinical Trials for Pharmaceutical Development.
Medpace Core Laboratories, a global full-service core laboratory, and Voximetry, a leader in advanced Radiopharmaceutical Therapy (RPT) dosimetry software and services, today announced a strategic partnership aimed at enhancing radiopharmaceutical clinical trials through the integration of cutting-edge dosimetry technology and comprehensive CRO services.
Through this agreement, Medpace has designated Voximetry as a preferred provider of dosimetry services for its radiopharmaceutical clinical trials. This strategic collaboration builds on a successful working relationship between the two companies since June 2024, during which Voximetry delivered consistent, high-quality dosimetry services supporting Medpace’s global clinical development programs.
